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Abstract
Background: The roll out of antiretroviral therapy in the South African public health sector in 2004 was preceded
by the politicisation of HIV-infection which was used to promote traditional medicine for the management of HIV/
AIDS. One decade has passed since; however, questions remain on the extent of the use of traditional,
complementary and alternative medicine (TCAM) by HIV-infected patients. This study therefore aimed at
investigating the prevalence of the use of African traditional medicine (ATM), complementary and alternative
medicines (CAM) by adult patients in the eThekwini and UThukela Health Districts, South Africa.
Methods: A cross- sectional study was carried out at 8 public health sector antiretroviral clinics using
interviewer-administered semi-structured questionnaires. These were completed from April to October 2014 by
adult patients who had been on antiretroviral therapy (ART) for at least three months. Use of TCAM by
patients was analysed by descriptive statistics using frequency and percentages with standard error. Where
the associated relative error was equal or greater to 0.50, the percentage was rejected as unstable. A p-value
<0.05 was estimated as statistically significant.
Results: The majority of the 1748 participants were Black Africans (1685/1748, 96.40 %, SE: 0.00045), followed
by Coloured (39/1748, 2.23 %, SE: 0.02364), Indian (17/1748, 0.97 %, SE: 0.02377), and Whites (4/1748, 0.23 %,
SE: 0.02324), p < 0.05. The prevalence of ATM use varied prior to (382/1748, 21.85 %) and after ART initiation
(142/1748, 8.12 %), p <0.05, specifically by Black African females both before (14.41 %) and after uptake
(5.49 %), p < 0.05. Overall, 35 Black Africans, one Coloured and one Indian (37/1748, 2.12 %) reported visiting
CAM practitioners for their HIV condition and related symptoms post ART.
Conclusion: Despite a progressive implementation of a successful antiretroviral programme over the first
decade of free antiretroviral therapy in the South African public health sector, the use of TCAM is still
prevalent amongst a small percentage of HIV infected patients attending public healthcare sector antiretroviral
clinics. Further research is needed to explore reasons for use and health benefits or risks experienced by the
minority that uses both conventional antiretroviral therapy with TCAM.
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Background
Human Immunodeficiency Virus (HIV) and Acquired
Immunodeficiency Syndromes (AIDS) are amongst the
biggest health challenges faced by African nations. The
last decade (2001–2010) saw many developing countries,
including South Africa, roll out successful antiretroviral
(ARV) programmes through a global advocacy initiative
to reduce the associated morbidity and mortality as well
as the cost of ARV medicines to overcome the health
care human resource crisis, to simplify the drug regi-
mens, monitor and improve the quality of care [1]. Glo-
bally people tend to use traditional medicine under the
terms complementary and alternative medicines (CAM),
including for HIV and other chronic conditions [2].
HIV-infected patients may turn for their health manage-
ment to public, private, household/self-care and other com-
munity based non-formal health sectors such as traditional
and faith healers, herbalists and other vendors [3]. In South
Africa, public sector healthcare is offered to patients with
HIV-infection at different levels of the health care system:
Primary Health Care (PHC) clinics, Community Health
Centres (CHC), District Hospitals (DH), Regional Hospitals
(RH), Academic Hospitals (AH) and Central Hospitals
(CH).
South Africa launched its first Operational Plan for
Comprehensive HIV and AIDS Care, Management and
Treatment with its national antiretroviral guidelines in
2004. During that time, HIV was highly politicised in the
country, with very senior officials denying the link between
HIV and AIDS; the latter was seen as a condition associated
with poverty in the socio-economic contexts of South
Africa [4]. The politicisation of HIV and AIDS was also
used before 2004 to promote traditional, complementary
and alternative medicines (TCAM) by senior government
officials who advocated the use of treatment modalities out-
side the orthodox system of HIV treatment, such as lemon
juice, beetroot and garlic [5]. The period after the introduc-
tion of highly active antiretroviral therapy (HAART) has
been marked by the political will towards promoting
universal access to antiretroviral therapy (ART) as well as
integrating traditional medicine into the public health care
sector [6]. The political support has resulted in South
Africa having one of the most successful public health
sector ARV programmes on the African continent, with at
least two million people receiving ART [7]. One critical
question remains however on the prevalence of TCAM use
a decade after easy access to ARV medicines was made pos-
sible by the government.
The World Health Organisation (WHO) defines African
traditional medicine (ATM) as “The sum total of all know-
ledge and practices, whether explicable or not, used in the
diagnosis, prevention and elimination of physical, mental,
or societal imbalance, and relying exclusively on practical
experience and observation handed down from generation
to generation, whether verbally or in writing” [8]. Other
forms of health care, such as Ayurveda and Traditional
Chinese medicine, which are not part of Africa’s own
traditional medicine category, are not integrated into the
dominant health care systems, but fall under CAM [9]. The
practice of African traditional healing in South Africa is
regulated by the Traditional Health Practitioners Act (Act
35 of 2004, further replaced by Act 27 of 2007) while the
practice of CAM is legally allowed under the Allied Health
Practitioners Act (Act 63 of 1982) and includes Ayurveda,
Traditional Chinese Medicine, Osteopathy, Chiropractic,
Homeopathy, Naturopathy, Phytotherapy, Therapeutic
Aromatherapy, Massage therapy, and Reflexology [10].
Some HIV infected patients who receive care at public
health sector ARV facilities may also use other methods of
healing/treatment, either indigenous to African communi-
ties or not; the prevalence and reasons for their use are not
well known.
South Africa has a diverse population made up of four
main ethnic groups, namely Black African (79 %), White
(9.6 %), Coloured (8.9 %) and Indian (2.5 %) [11]. How-
ever, the use of TCAM in combination with prescribed
ARVs by HIV patients from different racial groups is not
well known in the era of a successful ARV programme.
The use of TCAM by HIV –infected patients in KwaZulu-
Natal has been reported in the literature [12–14]. Data
from one such study conducted in KwaZulu-Natal showed
that TCAM was commonly used for HIV- infection during
the 6 months study period (317/638, 51.3 %) in combin-
ation with prescribed ART [15]. Concerns relating to the
safety of uncontrolled medicinal products have been raised
with reference to intrinsic toxicity and quality issues associ-
ated with TCAM; other risks include adverse drug reactions
such as liver toxicity reportedly associated with the use of
kava-kava [16] and drug interaction with ARVs and
medicinal plants [17]. Another concern is a delay reported
in starting with ART amongst HIV patients who use the
services of traditional healers in pre-ART phase in
Mozambique [18] whilst issues with HIV patients on ART
abandoning treatment for exclusively being managed by
prayers and faith healing were noted in Zambia [19]. Poor
adherence to ART was also noted with the concurrent use
of TCAM and ARVs [20]. Although studies reported poor
adherence in HIV patients on concurrent use of TCAM
and ART [21, 22], another study documented that patients
adhering to ART for HIV/AIDS also used CAM measures
such as homeopathy and herbal medicines for ARVs side-
effects, immune system enhancement, and overall well-
being [23]. This study therefore aimed at determining
whether HIV patients attending public health sector ARV
clinics still used TCAM for HIV-infection while on a
successful ARV programme. The specific objectives were to
determine the prevalence of the use of TCAM for HIV –in-
fection pre –ART and its ongoing use after starting with
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ARVs. In addition the study was conducted to ascertain
whether socio-economic status and/or the apartheid struc-
ture of the past had an influence on the use of TCAM by
HIV infected patients.
Methods
Study design and sites
A descriptive cross sectional study was conducted from
April to October 2014 using a questionnaire with both
closed-ended and open-ended questions administered
through face to face interviews to HIV- infected patients
attending public healthcare sector ARV clinics. Fourteen
ARV clinics at different levels of care were approached to
be part of the study, but permission was obtained from
eight clinics situated in the eThekwini and uThukela
health districts. The ARV clinics were from three regional
hospitals (RH), one academic hospital (AH), two district
hospitals (DH), and two community health centres
(CHC). Study sites in eThekwini consisted of three ARV
clinics located in previously designated Black African
communities, two ARV clinics situated in a previously
designated Coloured community, and a previously desig-
nated Indian community, whilst another clinic was in an
informal urban settlement and the last site in Ethekwini
Metro was in a previously White designated area. The
ARV site in UThukela health district was located in a
town, previously designated for the White community.
All of the 8 clinics were mainly in the metropolitan
and urban types of settlement in both sampled health
districts [24]. The South African National Department
of Health (NDOH) paid a rural allowance to healthcare
professionals depending on the type of locality and place
of health facilities; some metropolitan settlements have
those types of locality qualifying for rural allowance like
in normal rural areas. The description of ARV clinics by
the designator ‘with or without allowance’ was used in
this analysis to distinguish the type of locality and place
of clinics. For anonymity and confidentiality the eight
ARV sites were coded according to their designated level
as: RHRA1, RHRA2, RHNRA3, AHNRA4, DHRA5,
DHNRA6, CHCRA7 and CHCNRA8, with the suffixes
RA and NRA referring to rural and non-rural allowance
paid to health care professionals, respectively and the
prefixes were the type of healthcare facility, for example,
RH (Regional hospital), AH (.Academic hospital), DH
(District hospital) and CHC (Community health centre).
Study sample size assumption
A sample size was calculated using a formula previously
described in the literature [25, 26]. The assumption for
the calculation of the sample size (n) was based on an
expected prevalence (P) of 50 % on the use of TCAM
among study participants, with a precision (d) of ±5 %
and a level of confidence interval at 95 %. This yielded a
minimum sample size of 384. This study was conducted
at four levels of care (academic, regional, district hospi-
tals and community health centres). To maintain this
precision across antiretroviral sites per level of care, the
minimum sample size was multiplied by four and was
estimated at 384*4 = 1536 participants. To allow for drop
–outs and unforeseen circumstances, the sample size
was oversampled by 15 % for a maximum of 1766 partic-
ipants, irrespective of gender. But for logistic reasons,
time constraints and willingness of participants to be
part of the study during data collection, 1748 adult
volunteers were recruited and included in this analysis.
Ethical approval
This study was approved by the Biomedical Research Ethics
Committee (BREC) of the University of KwaZulu-Natal;
under reference number BE 377/13. Participation was
voluntary; no patients were included in this research study
without their prior consent. No names and identity of
participants appeared on any consent form, but only a
signature and a coded identification known to the
researchers. All questionnaires were coded to ensure ano-
nymity and confidentiality. Questionnaire readily available
in English and Zulu allowed a choice of a preferred
language by study participants. Field workers, who collected
data, were briefed about the study and the importance of
maintaining confidentiality and anonymity of the study
participants.
Recruitment process and selection of participants
Study participants were all HIV infected adult patients,
aged 18 years and above, irrespective of gender. Adult
patients visiting the ARV clinic on the days of data collec-
tion and who satisfied the inclusion criteria were eligible
to participate in the study. Participants were approached
when entering the premises of the ARV clinic and were
asked if they would like to participate in the study. An
information sheet/letter about the study was given or
explained to them. Those who agreed to participate were
requested to give and sign consent before being inter-
viewed. Only patients who were on HAART for at least 3
months were included in the final analysis.
Data collection technique and instrument
A semi-structured questionnaire with both close- and
open-ended questions was used to conduct face to face
interviews by a team of trained field workers. Interviews
were conducted once off, face to face by one member of
the research team, in the language of preference of the
study participants, which was either Zulu or English.
The questionnaire included amongst others socio-
demographic characteristics of participants and a section
on the use of TCAM for the management of HIV-
infection prior to and after starting with ART. For this
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analysis one such question stated” Have you ever used
TCAM for the management of HIV-infection prior to
and after starting with ART? If yes, please list the cat-
egory of traditional healer visited for your HIV condition
before and after starting with ARVs.” Other sections of
the questionnaire related to reasons and factors associ-
ated with use of TCAM for HIV and non –HIV related
problems, and or perceived benefits/risks of TCAM; the
results of the latter have not been included in this paper.
Statistical analysis
Data captured on Excel sheet was managed and analysed
using the Software Package for Social Sciences (SPSS),
version 22 for Windows; SPSS Inc,2014–2016 (Chicago,IL).
Results were presented as frequency and percentages with
standard error (SE). Where the associated relative error was
equal or greater to 0.50, the percentage was rejected as
unstable. Categorical variables were presented as frequency
with tables or graphs. Pearson chi-square was performed
for most of the variables; with exceptions of certain cases
where Fischer’s Exact or McNemar tests were more appro-
priate to determine the level of significance. Bivariate ana-
lyses were used to assess socio-demographic characteristics
in relation to the use of ATM pre ART as well as ATM and
CAM use post ART. The influence of socio-demographic
characteristics on the odds of using ATM and CAM for
HIV infection was estimated for each characteristic by a
multivariable logistic regression including 95 % confidence
intervals for odds ratio and p –values. A p-value < 0.05 or
better was estimated as statistically significant.
Results
Response rate
Face to face interviews were completed with 1748
respondents out of the targeted maximum sample of
1766 participants, yielding a response rate of 98.98 %.
Socio- demographic characteristics of the study
population
Participants were predominantly Black Africans (1685/
1748, 96.40 %, SE: 0.00045), followed by Coloured (2.23 %,
SE: 0.02364), then by Indian (0.97 %, SE: 0.02377) and
negligible White participants (0.24 %, SE: 0.02324), p –
value < 0.05. Participants were mostly Zulu speakers
(87.93 %, SE:0.00831), Christians (77.00 %, SE:0.01148),
never married (75.74 %, SE:0.01178), females (73.80 %,
SE:0.01224), aged between 31 and 45 years old (58.12 %,
range 18–66), had high school education (1259/1748,
72.03 %), were unemployed and had no formal income
(58.98 %, SE:0.01532) while the majority (33.47 %) of those
with income made less than R100 000 per annum (US $1
= ZA R12 at the time of data collection). Socio-
demographic characteristics are presented in Table 1.
Table 1 Socio-demographic characteristics of study participants
(n = 1748), 2014
Variable Category No. % Standard error
Gender Male 458 26.20 0.02055
Female 1290 73.80 0.01224
Age in years 18–30 282 16.13 0.02351
31–65 1442 82.49 0.02340
≥66 15 0.86 0.02148
Missing value 9 0.51 0.02374
Racial group African 1685 96.40 0.00454
Coloured 39 2.23 0.02364
Indian 17 0.97 0.02377
White 4 0.23 0.02324




Married 319 18.25 0.02162




Widow 19 1.09 0.02382
Missing value 6 0.34 0.02376







English 57 3.26 0.02352
Afrikaans 2 0.11 0.02343
Urdhu 1 0.05 0.02449
Missing value 4 0.22 0.02395
Highest education
level
Primary school 332 18.99 0.02277




Higher certificate 82 4.69 0.02335













8333–16666.6) 86 4.92 0.02332
16750–25000) 12 0.69 0.02390
25083–33333.3) 5 0.29 0.02405
33417–41667) 2 0.11 0.02344
4 0.22 0.02342
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Prevalence of the use of TCAM for HIV-infection pre and
post ART
There was a decrease in ATM use for HIV infection post
ART by a total of 13.73 % from 382 (21.85 %) to 142 par-
ticipants (8.12 %), p-value < 0.05. A few participants (37/
1748, 2.12 %) reported the use of CAM post ART for HIV
infection (p = 0.920). Table 2 presents the frequency of the
use of ATM and CAM pre and post ART by study
participants.
Prior to ART 382 out of 1748 participants (21.85 %) re-
ported ATM use for the management of HIV infection.
Majority of attendees of public sector healthcare ARV
clinics were Black Africans who also reported more the use
of TCAM for HIV prior to and post ART than those partic-
ipants from the other three racial groups. Very few
Coloured (3/1748), Indian (2/1748) and White participants
(1/1748) agreed to have used ATM for HIV prior to ART
compared to the majority of Black Africans (376/1748).
Overall 37 participants including 35 Black Africans, one
Coloured and one Indian (37/1748, 2.12 %) reported CAM
use. None of the few White participants continued with
ATM and or resorted to CAM use post ART. The use of
CAM (37/1748, 2.12 %) was lower than ATM use (142/
1748, 8.12 %) for HIV infection in the post ART phase.
There were more Zulu speakers than other categories
of home languages who resorted to ATM prior to (336/
1748, 19.22 %) and after (125/1748, 7.15 %). Single par-
ticipants have used more ATM than other categories of
marital status prior to (285/1748, 16.30 %) and after
ART (106/1748, 6.06 %), p < 0.05. Almost all age groups
in this study used ATM healers prior to and post ART,
suggesting that age was a constant variable with a rela-
tively high proportion of users aged between 31 and
50 years old prior to (268/1748, 15.33 %) and after ART
(102/1748, 5.84 %), p-value < 0.05.
Almost none of the few participants (19/1748,1.08 %)
with income between R 201000-300000 ($16750–41667)
had ever used ATM prior to and after ART. Being un-
employed with no formal income was associated with a
high proportion of participants' use of ATM prior to (178/
1748, 10.18 %) and post ART (74/1748, 4.23 %), with a sig-
nificant difference (p < 0.05.). Participants with high school
education (101/1748, 5.78 %) used more ATM healers and
CAM practitioners (27/1748, 1.54 %) than those with pri-
mary and post- secondary education.
Frequency of the use of TCAM by income category,
level of education and religious affiliations is presented
in Table 3.
The majority of ATM users and those who consulted
CAM practitioners were Christians. No Hindu partici-
pant reported using ATM or CAM practitioners pre and
post ART whilst very few Muslims (5/1748) used ATM
for HIV pre –ART. Comparisons of sample characteris-
tics and the use of ATM healers prior to and after ART
were performed using Chi-square tests.
Female participants used more ATM prior to (252/1748,
14.41 %) and post ART (96/1748, 5.49 %) than males; many
more women resorted post ART to the services of CAMprac-
titioners for HIV (29/1748) than males (8/1748) in both types
of locality and levels of care of clinics. Gender differences in
the use of ATM prior to and post ART (p-value < 0.05) are
illustrated in Fig. 1.
Current utilization of ARV clinics by study participants per
types of locality and levels of care of clinics
In spite of inclusion of four ARV clinics situated in
areas previously designated for the other three racial
groups, current utilization of ARV clinics was mostly
and actually dominated in both types and locality of
clinics by Black African attendees.
The majority of participants were from clinics ‘without
rural allowance’ coded NRA as suffix (1111/1748,
63.56 %) vs clinics ‘with rural allowance’ and coded RA
as suffix (637/1748, 36.44 %), p-value <0.05. Table 4 pre-
sents the current utilization of clinics.
Use of TCAM by type of locality and level of care of ARV
clinics by study participants
Prior to ART this study found as many participants from
clinics without rural allowance (193/1748, 11.04 %) who
used ATM healers as from clinics with rural allowance
(189/1748, 10.81 %). However; post ART, there were
many more participants from clinics without rural allow-
ance (89/1748, 5.09 %) who used some types of ATM in
combination with prescribed ARVs than those from
clinics with rural allowance (53/1748, 5.03 %), p-value <
0.05. Overall, participants attending district hospitals
used more ATM post ART (89/1748, 7.95 %) than those
attending community health centres (31/1748, 1.77 %),
Table 1 Socio-demographic characteristics of study participants
(n = 1748), 2014 (Continued)
Self-employed &
undisclosed income
Missing value 23 1.32 0.02380
Religious
affiliation
Christians 1401 80.14 0.01148









Muslims 14 0.80 0.02381
Hindus 7 0.40 0.02386
Missing value 4 0.22 0.02395
Legend: SA= South African
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regional and academic hospitals combined (22/1748,
1.26 %), p-value < 0.05. This suggests the role of services
of healthcare facilities in the decrease of the use of ATM
healers and CAM practitioners. Figure 2 illustrates the
use of TCAM by type of locality and level of care of
clinics prior to and post ART.
Prevalence of the use of CAM practitioners was higher
in ARV clinics with rural allowance (21/1748,1.20 %)
than in those clinics without rural allowance (16/
1748,0.92 %), p-value <0.05. The use of ATM prior to
and post ART varied significantly per ARV clinic/health
facility (p = 0.000) and type of locality of ARV clinic with
or without rural allowance (p = 0.000). level of care Post
ART the use of CAM per level of care (p = 0.000) and
location of ARV clinics (p = 0.010) was statistically
significant.
Table 2 ATM and CAM use by gender, racial group, age and home language, 2014
Variable Total sample
(N = 1748)
ATM use prior to ART
(n = 382)








Male 458 130 46 0.000 8 0.791
Female 1290 252 96 0.000 29
Racial group
Black 1685 377 139 0.000 c 35 0.920
Coloured 39 3 2 0.000 d 1
Indian 17 1 1 0.000 1
White 4 1 0 0.000 0.
Age (years)
18–19 29 5 1 0.029 0 0.373
20–25 74 17 5 0.000 1
26–30 179 39 13 0.000 6
31–35 337 74 23 0.000 6
36–40 374 70 28 0.000 10
41–45 305 78 33 0.000 4
46–50 187 46 18 0.000 3
51–55 132 20 4 0.000 5
56–60 77 22 11 0.000 0
61–65 30 9 4 0.001 2
≥66 15 2 2 0.000 0
Marital status
Single 1324 285 106 0.000 27 0.018
Married 319 67 26 0.000 6
Divorced 21 3 1 0.012 0
Living with partner 59 26 9 0.001 4
Widow 19 1 0 NA 0
Home language
Zulu 1537 336 125 0.000 34 0.000
Other African
languages




70 18 4 0.000 1
English 57 21 9 0.000 0
Afrikaans 2 0 0 NA 0
Urdhu 1 1 0 NA 1
ART antiretroviral therapy, ATM African traditional medicine, NA not applicable
Legend: a: Cross tabulations and Chi-square tests were performed; b Non-parametric tests were performed; c Pearson Chi-square, dFisher’s Exact
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Bivariate and multivariate analysis of use of ATM and
CAM by participants
Bivariate analyses indicated that having an income cat-
egory ≤R 100,000 (US$ 8,333.3 at the time of data collec-
tion) and being Christian was associated with the use of
ATM post ART while conversely no socio-demographic
characteristic was significantly associated with CAM use
post ART. Female gender, being Black and Christian for
religious affiliation, having completed high school, post-
secondary higher certificate, diploma and degree, gaining
an income of ≤R 100,000 and ≥100,000 (US $ 8,333.3) were
Table 3 Frequency of ATM and CAM use by income category, level of education and religion (n = 1748)
Highest education level Total sample
(N = 1748)
ATM use prior to ART
(n = 382)
ATM use post ART
(n = 142)
Chi-square P-value a CAM use post ART
(n = 37)
p-valueb
Some primary school 163 48 18 0.000 3 0.421
Completed primary school 169 44 14 0.000 3
Some high school grade 7
to grade 11
700 156 54 0.000 18
Completed high school 559 109 47 0.000 9
Post high school diploma 40 3 0 NA 1
Higher certificate 82 14 5 0.000 1
Bachelor degree 13 3 2 0.005 1
Never attended school
and other
15 4 2 0.035 1
Missing value 7 1 0 NA 0
Income situation
Unemployed and no formal
income
1031 178 74 0.000 19 0.274
≤R 100 000 ($8333.3) 585 159 60 0.000 16
8333–16666.6) 86 37 4 0.030 1
16750–25000) 12 1 0 NA 0
25083–33333.3) 5 0 0 NA 1
33417–41667) 2 0 0 NA 0
Self-employed and
undisclosed income
4 2 2 0.135 0
Missing value 23 5 2 0.046 0
Religious affiliation
Christian 1345 249 89 0.000 24 0.725
Shembe 140 47 18 0.000 6
Zion Christian Church (ZCC) 97 36 23 0.000 4
Atheist 54 8 2 0.000 0
Believers in ancestors/
traditional Zulu
31 18 4 0.000 1
Muslims 14 5 0 NA 0
Hindus 7 0 0 NA 0
Other (St Johns,Chibihi, Wisile) 56 18 6 0.000 2
Missing value 4 1 0 NA 0
ART antiretroviral therapy, ATM African traditional medicine, NA not applicable
Legend: a: Cross tabulations and Chi-square tests were performed; b Non parametric tests were performed
Fig. 1 Gender differences in the use of African traditional medicine
prior and after joining antiretroviral programmes, 2014
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significantly associated with ATM use prior to ART (see
Table 5 below).
In the multivariate logistic regression being Chris-
tian was confirmed to be associated with the use of
ATM for HIV infection post ART (OR 0.46, 95 % CI
0.32–0.66, p-value < 0.001). The lack of association of
socio-demographic characteristics with CAM use post
ART was confirmed in the multivariate analysis. How-
ever, female gender, being black and Christian for re-
ligious affiliation, having completed high school, post-
secondary higher certificate, diploma and degree, and
gaining income were confirmed in the multivariate
model as associated with the use of ATM prior to
ART. Table 5 presents the bivariate and multivariate
analyses for the use of ATM and CAM by study
participants.
Discussion
This study found that a few HIV patients still used ART
concurrently with TCAM for their HIV-infection a dec-
ade after the implementation of a successful ARV
programme in South Africa. However there was a de-
crease on the use of TCAM evidenced by a drop in the
percentage of participants that took TCAM prior to
(21.85 %) and post ART (8.12 %). This finding is consist-
ent with data obtained from other studies. In one such
study conducted between October 2007 and February
2008 in KwaZulu-Natal the authors reported a decline in
prevalence of complementary or traditional treatments
in HIV-infected patients from 36.6 % prior to ART to
7.9 % after 6 months on ART [12]. In another longitu-
dinal follow-up study the authors reported a further
decrease in TCAM at 12 and 20 months post ART [27].
The utilization of public sector ARV clinics in this study
was predominantly by Black African females with the
majority reporting being single and never married. Many
more females used ATM healers and visited CAM practi-
tioners in the post ART era than males as evidenced in
this study. The lower percentage of males visiting ARVcli-
nics could be supported by another study that found that
men reported several barriers to the use of public and
private clinics for sexual health services in Gauteng prov-
ince (South Africa), and many preferred the services of
traditional healers for sexually –transmitted –infections
[28]. Another study found an increased use of CAM
amongst women in rural areas in Australia [29].
Almost none of the participants in the relatively high
income bracket/category had used ATM healers or
CAM practitioners post ART, this is in contrast with
findings of another study done amongst African-
Americans where the high income category afforded
participants to use CAM for treatment [30]. However,
the finding of this study was consistent with the findings
from a national household survey on the utilization of
traditional healers in South Africa which showed that
the wealthiest had a tendency neither to consult trad-
itional healers nor to use public sector healthcare facil-
ities for health issues [31]. This may justify the high
number of Black African HIV patients attending public
sector ARV clinics, with a few Coloured, Indian and
White participants also not reporting a substantial use
of TCAM.
The role played by the type of dwelling and the the
participants’ place of residence place and locality of
clinics has been demonstrated by patients in seeking
Table 4 Types of locality of clinics and utilization of clinics by











RHRA1 Township Black African 111 (6.35)
Subtotal 111 (6.35)






























Legend: AH academic hospital, CHC community health centre, DH district
hospital, RH regional hospital, NRA non- rural allowance
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care after traditional healers [32]. We found that there
was no significant difference between the types of local-
ity and place of clinics and the use of ATM prior to
ART, but there was a significant decline in the preva-
lence of the use of ATM healers and CAM practitioners
after joining the ARV programme. The use of TCAM in
the pre-ART phase may have been due to the unafford-
ability and inaccessibility of HAART. People had to find
alternate means to manage their HIV condition. A few
participants in this study visited CAM practitioners for
HIV infection (37/1748, 2.12 %) when compared to
ATM healers (142/1748, 8.12 %). Patterns of CAM use
and ethnic-specific CAM use vary across racial/ethnic
groups demonstrating the role of culture in choices of
the use of CAM practitioners [33].
From this study and other previous studies we can
hypothesize that the introduction and progressive free
access to ART in public sector healthcare facilities
have contributed to the decline in the use of TCAM
amongst South African HIV infected patients a dec-
ade after the roll-out of ARV programme. Challenges
of pharmacological interactions caused by concomi-
tant use of traditional herbal therapies and conven-
tional antiretroviral medicines should be a cause of
concern for quality of care offered to patients and
should be investigated further for risk of clinically
significant pharmacokinetic (PK) interactions [17].
Since a low percentage of HIV patients in this study
still used TCAM for HIV-infection, further studies are
needed to determine reasons and factors associated with
the use of TCAM, and or benefits/risks of concurrent use
of TCAM with ART while on a successful programme.
Strengths and limitations of the study
This study included a reasonable sample size and looked
at the diverse population of South Africa. The response
rate was very satisfactory to meet expectations of more or
less 80 %, with acceptable reliability and validity for this
type of research [34]. The percentage of missing value for
almost all variables in this study was very low, if not negli-
gible. As part of limitations there might be a recall bias
which could have affected the categories of ATM healers
and CAM practitioners reported by participants. This
study discussed the use of ATM differentiated to CAM
use as defined in the context of South Africa. This study
looked at public sector healthcare ARV programme; no
attempt was made to understand the phenomenon in the
private sector healthcare system. The study sample was
exclusively made of patients attending public health sector
ARV clinics and it did not include the general population;
therefore findings cannot be generalized to the entire
population of persons living with HIV infection in the
study sites or South Africa. The study was conducted
during clinic visit hours, not allowing participants full
freedom of expression, which could have influenced the
participants’ response on the use of TCAM.
Conclusions
A decade after the introduction of ART and despite the
success of the public health sector ARV programme in
Fig. 2 Use of ATM by type of locality and level of care of clinics, 2014
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Table 5 Odds ratios (OR) and 95 % confidence intervals (CI) for ATM and CAM use, bivariate and multivariate analyses
Variable Use of ATM prior to ART(yes = 382,No = 1365) Use of ATM post ART(Yes = 142, No = 1602) Use of CAM post ART(Yes = 37, No = 1710)
Bivariate
OR (95 % CI)
p-value Multivariable
OR (95 % CI)
p-value Bivariate
OR (95 % CI)
P-value Multivariate
OR (95 % CI)
p-value Bivariate
OR (95 % CI)




Male 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Female 0.61 (0.48,0.78) <0.001 0.69 (0.53,0.89) 0.005 0.72 (0.5,1.04) 0.079 0.76 (0.52,1.11) 0.152 1.11 (0.52,2.37) 0.788 1.17 (0.54,2.54) 0.683
Race
other 1 (ref) 1 (ref) 0.005 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Black 3.17 (1.26,7.98) 0.014 3.87 (1.43,10.49) 0.008 1.71 (0.53,5.54) 0.369 1.91 (0.53,6.84) 0.323 1.29 (0.17,9.57) 0.804 0.75 (0.08,7.44) 0.806
Age
≤ 30 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
> 30 1 (0.75,1.33) 0.985 0.88 (0.65,1.2) 0.427 1.09 (0.7,1.72) 0.693 1.02 (0.64,1.6) 0.947 0.72 (0.33,1.53) 0.389 0.66 (0.31,1.43) 0.293
Marital status
Not in union 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Married or living with partner 1 (1,1) 0.766 1 (1,1) 0.776 1 (1,1) 0.453 1 (1,1) 0.258 1.34 (0.64,2.8) 0.431 1 (0.96,1.04) 0.868
Mother tongue
Non-Zulu 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Zulu 0.98 (0.69,1.39) 0.91 0.71 (0.48,1.05) 0.089 0.99 (0.58,1.68) 0.977 0.83 (0.47,1.49) 0.539 1.54 (0.47,5.06) 0.477 1.62 (0.41,6.32) 0.488
Education Bivariate
OR (95 % CI)
p-value Multivariable
OR (95 % CI)
p-value Bivariate
OR (95 % CI)
P-value Multivariate
OR (95 % CI)
p-value Bivariate
OR (95 % CI)
p-value Multivariable OR (95 %
CI)
p-value
Primary 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Some high school 0.75 (0.55,1.01) 0.057 0.74 (0.54,1.02) 0.064 0.79 (0.5,1.24) 0.303 0.83 (0.52,1.34) 0.45 1.44 (0.56,3.65) 0.447 1.41 (0.55,3.62) 0.480
Grade 12 0.63 (0.46,0.87) 0.005 0.61 (0.43,0.86) 0.005 0.86 (0.54,1.38) 0.543 0.92 (0.56,1.52) 0.739 0.89 (0.31,2.53) 0.828 0.85 (0.29,2.48) 0.762
Higher certificate, diploma,
degree
0.5 (0.3,0.82) 0.006 0.46 (0.27,0.78) 0.004 0.6 (0.28,1.29) 0.189 0.67 (0.31,1.47) 0.318 1.49 (0.41,5.35) 0.542 1.49 (0.4,5.48) 0.551
Income
None 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
≤ R100 000 1.78 (1.4,2.28) <0.001 1.92 (1.49,2.49) <0.001 1.48 (1.03,2.11) 0.032 1.44 (0.99,2.09) 0.054 1.49 (0.76,2.93) 0.243 1.58 (0.79,3.16) 0.199
> R 100 000 2.73 (1.79,4.16) <0.001 3.38 (2.18,5.25) <0.001 0.75 (0.32,1.77) 0.512 0.85 (0.36,2.03) 0.714 0.98 (0.23,4.28) 0.982 1.07 (0.24,4.77) 0.925
Religion
Other 1 (ref) <0.001 1 (ref) <0.001 1 (ref) 1 (ref) 1 (ref) 1 (ref)





















South Africa, the use of TCAM is still prevalent amongst a
small percentage of HIV infected patients attending public
sector healthcare ARV clinics. In the pre-ART phase, many
patients tend to use TCAM. However, there is a decrease in
the use of TCAM in the post ART phase. An hypothesis
can be assumed that free access to ART may account in the
decrease of the use of TCAM by HIV patients. Public
sector healthcare ARV clinics are mainly used by Black
African patients, with a few patients from the other racial
groups. Although the majority of patients did not report
using TCAM while on ART, further research is needed to
explore reasons for use and health benefits or risks experi-
enced by the minority that uses both conventional anti-
retroviral therapy and traditional medicine.
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